Triple
T11074773
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | CLEOPATRA trial |
E261834
|
entity |
| Predicate | sponsor |
P67
|
FINISHED |
| Object | F. Hoffmann-La Roche |
E46707
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: F. Hoffmann-La Roche | Statement: [CLEOPATRA trial, sponsor, F. Hoffmann-La Roche]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: F. Hoffmann-La Roche Context triple: [CLEOPATRA trial, sponsor, F. Hoffmann-La Roche]
-
A.
Roche
Roche is a common surname of French origin borne by various notable individuals across fields such as architecture, politics, and the arts.
-
B.
Roche
chosen
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
-
C.
Fritz Hoffmann-La Roche
Fritz Hoffmann-La Roche was a Swiss entrepreneur and industrialist who founded the global healthcare and pharmaceutical company Roche in the late 19th century.
-
D.
Novartis
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
-
E.
Ciba-Geigy
Ciba-Geigy was a major Swiss pharmaceutical and chemical company that became one of the predecessors of Novartis after its merger with Sandoz in 1996.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d6aa9983c08190b0ef61603b69feac |
completed | April 8, 2026, 7:20 p.m. |
| NER | Named-entity recognition | batch_69d7994efb608190a81bc8c4d16ddbd0 |
completed | April 9, 2026, 12:19 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69e3e77a78288190aa76912e0fa821b5 |
completed | April 18, 2026, 8:20 p.m. |
Created at: April 8, 2026, 9:26 p.m.